H S Azzam1, C Goertz, M Fritts, W B Jonas. 1. Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, MD 21201-1596, USA. hazzam@epi.umaryland.edu
Abstract
BACKGROUND: Chronic hepatitis C virus (HCV) infection is a significant public health problem, with a worldwide prevalence of approximately 170 million. The standard of care for chronic HCV, a combination of alpha-interferon (IFN) and ribavirin, is only 50% effective, has serious side effects, and can be prohibitively expensive for low-income countries with a high prevalence of HCV. Many patients use natural products, including those who are not eligible for IFN/ribavirin, cannot afford treatment, or fail to respond to IFN. METHODS: Extensive literature searches were conducted in order to identify clinical trials and reviews of natural products used for treatment of chronic HCV. This review focuses on the composition, pharmacology and results of clinical trials of three natural products: Oxymatrine, TJ-108/schisandra/Gomisin A and lactoferrin. RESULTS: Several laboratory and human studies have been performed to evalaute these alternative treatments, but many of these studies are small, uncontrolled and have other important design flaws. While they do offer some safety and efficacy data, none of these studies is conclusive. CONCLUSION: Further research is needed on the effectiveness of these natural products for treatment of chronic HCV, including their preparation and standardization.
BACKGROUND:Chronic hepatitis C virus (HCV) infection is a significant public health problem, with a worldwide prevalence of approximately 170 million. The standard of care for chronic HCV, a combination of alpha-interferon (IFN) and ribavirin, is only 50% effective, has serious side effects, and can be prohibitively expensive for low-income countries with a high prevalence of HCV. Many patients use natural products, including those who are not eligible for IFN/ribavirin, cannot afford treatment, or fail to respond to IFN. METHODS: Extensive literature searches were conducted in order to identify clinical trials and reviews of natural products used for treatment of chronic HCV. This review focuses on the composition, pharmacology and results of clinical trials of three natural products: Oxymatrine, TJ-108/schisandra/Gomisin A and lactoferrin. RESULTS: Several laboratory and human studies have been performed to evalaute these alternative treatments, but many of these studies are small, uncontrolled and have other important design flaws. While they do offer some safety and efficacy data, none of these studies is conclusive. CONCLUSION: Further research is needed on the effectiveness of these natural products for treatment of chronic HCV, including their preparation and standardization.
Authors: Mohamed Ali Ibrahim; MinKyun Na; Joonseok Oh; Raymond F Schinazi; Tami R McBrayer; Tony Whitaker; Robert J Doerksen; David J Newman; Louis G Zachos; Mark T Hamann Journal: Proc Natl Acad Sci U S A Date: 2013-09-30 Impact factor: 11.205
Authors: Dun Linglu; Li Yuxiang; Xu Yaqiong; Zhou Ru; Ma Lin; Jin Shaoju; Du Juan; Sun Tao; Yu Jianqiang Journal: Neurol Sci Date: 2013-12-14 Impact factor: 3.307
Authors: Paula Cordero-Pérez; Liliana Torres-González; Marcelino Aguirre-Garza; Carlos Camara-Lemarroy; Francisco Guzmán-de la Garza; Gabriela Alarcón-Galván; Homero Zapata-Chavira; Ma de Jesús Sotelo-Gallegos; Cipactli Nadjedja Torres-Esquivel; Ethel Sánchez-Fresno; Daniel Cantú-Sepúlveda; Gerardo González-Saldivar; Judith Bernal-Ramirez; Linda E Muñoz-Espinosa Journal: Pharmacognosy Res Date: 2013-07
Authors: Jong-Woo Kim; Sang Jin Park; Jong Hwan Lim; Jae Won Yang; Jung Cheul Shin; Sang Wook Lee; Joo Won Suh; Soon B Hwang Journal: Evid Based Complement Alternat Med Date: 2013-12-15 Impact factor: 2.629